Clinical and genetic heterogeneity in myotonic dystrophies

Muscle and Nerve

Volumn 23, Issue 12, 2000, Pages 1789-1799

  Meola, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Allelic heterogeneity; Clinical heterogeneity; DM1; DM2; Genetic heterogeneity; Myotonic dystrophies; Proximal myotonic dystrophy; Proximal myotonic myopathy

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CORTICOSTEROID; DNA; MEXILETINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN;

CHROMOSOME 19Q; CHROMOSOME 3Q; DISEASE CLASSIFICATION; GENE LOCUS; GENETIC LINKAGE; HUMAN; MUSCLE DISEASE; MYOTONIA; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; REVIEW;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 3; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOTONIC DYSTROPHY;

EID: 0033653152     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4     Document Type: Review

References (98)

1. Myotonic dystrophy phenotype without expansion of (CTG)n repeat: A distinct form of proximal myotonic myopathy (PROMM)?
2. Brain proton magnetic resonance spectroscopy and brain atrophy in myotonic dystrophy
3. Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy
4. Somatic instability of CTG repeat in myotonic dystrophy
5. + channels in myotonic dystrophy
6. Molecular basis of myotonic dystrophy: Expansion of trinucleotide (CTG) repeat at the 3' end of a transcription encoding a protein kinase family member
7. Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM)
8. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy
9. From mutation to myotonia in sodium channel disorders
10. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2)
11. Cardiac involvement in patients with myotonic dystrophy: Characteristic features of magnetic resonance imaging
12. Personality patterns in patients with myotonic dystrophy
13. Proximal myotonic myopathy (PROMM). Clinical variability within a family
14. Biochemical Studies of DM Protein Kinase (DMPK)
15. A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel
16. An unstable triplet repeat in a gene related to myotonic muscular dystrophy
17. Proximal myotonic myopathy: Report of three families
18. Effect of testosterone on muscle protein synthesis in myotonic dystrophy
19. Lack of relationship of hypogonadism to muscle wasting in myotonic dystrophy
20. Hypothyroidism unmasking proximal myotonic myopathy (PROMM)
21. Expanding complexity in myotonic dystrophy
22. Myotonic dystrophy: The correlation of (CTG) repeat length in leucocytes with age at onset is significant only for patients with small expansions
23. Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighbouring genes
24. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy
25. Myotonic dystrophy as a trinucleotide repeat disorder - A clinical perspective
26. CTG-repeat length in distal and proximal leg muscles of symptomatic and nonsymptomatic patients with myotonic dystrophy: Relation to muscle strength and degree of histopathological abnormalities
27. A patient with muscle pain after a journey to the tropics. Myocardial involvement in proximal myotonic myopathy
28. Proximal myotonic myopathy with MRI white matter abnormalities of the brain
29. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1)
30. Congenital myotonic dystrophy pathology and somatic mosaicism
31. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP
32. Treatment of myotonia with antiarrhythmic drugs
33. Proximal weakness as the primary manifestation of myotonic dystrophy in older adults
34. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy
35. Voltage-gated ion channels and hereditary diseases
36. Hereditary non-dystrophic myotonias and periodic paralysis
37. Human sodium channel myotonia: Slowed channel inactivation due to substitutions for a glycine within the III-IV linker
38. Myotonic dystrophy: Phenotype-genotype and insulin resistance
39. Myotonic dystrophy mutation: An unstable CTG repeat in the 3' untranslated region of the gene
40. Clinical and neuroimaging study of central nervous system in congenital myotonic dystrophy
41. Somatic instability of the myotonic dystrophy (CTG)n repeat during human fetal development
42. Comparison of CTG repeat length expansion and clinical progression of myotonic dystrophy over a five-year period
43. Myotonic dystrophies - How many are there?
44. Dominantly inherited proximal myotonic myopathy and leukoencephalopathy in a family with an incidental CLCN1 mutation
45. A 10-year study of mortality in a cohort of patients with myotonic dystrophy
46. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada)
47. Myotonic disorders: Myotonic dystrophy and proximal myotonic myopathy
48. A newly described myotonic disorder (proximal myotonic myopath - PROMM): Personal experience and review of the literature
49. Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy
50. Proximal myotonic myopathy (PROMM) five-year follox-up study. A relatively benign disorder?
51. A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): A challenge for future molecular studies
52. Dominant multi-system proximal myotonic myopathic syndromes: Clinical and genetic heterogeneity in three families
53. Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert
54. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: Small pool PCR
55. RNA metabolism in myotonic dystrophy: Patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance
56. Myotonic muscular dystrophy
57. Proximal myotonic myopathy: Mini-review of a recently delineated clinical disorder
58. Insulin resistance in proximal myotonic myopathy (PROMM)
59. 54th ENMC International Workshop: PROMM (proximal myotonic myopathies) and other proximal myotonic syndromes - Workshop report
60. Proximal myotonic myopathy (PROMM) presenting as myotonia during pregnancy
61. Cardiac disease in myotonic dystrophy
62. PROMM: The expanding phenotype. A family with proximal myopathy, myotonia and deafness
63. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita and hyperkalemic periodic paralysis
64. Genetic mapping of a second myotonic dystrophy locus
65. Expression of apamin receptor in muscles of patients with myotonic muscular dystrophy
66. Myotonic dystrophy and proximal myotonic myopathy
67. Linkage of proximal myotonic myopathy to chromosome 3q
68. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts
69. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy
70. Thornton-Griggs-Moxley disease: Myotonic dystrophy type 2
71. Abnormalities of the fast sodium current in myotonic dystrophy, recessive generalized myotonia, and adynamia episodica
72. Heat-sensitive myotonia in proximal myotonic myopathy
73. The exercise test distinguishes proximal myotonic myopathy from myotonic dystrophy
74. Direct detection of novel expanded trinucleotide repeats in the human genome
75. Anticipation in proximal myotonic myopathy
76. Proximal myotonic myopathy. Analysis of 3 Swedish cases
77. Carbamazepine versus diphenylhydantoin in the treatment of myotonia
78. Direct diagnosis of myotonic dystrophy with a disease-specific DNA marker
79. Myotonic dystrophy. The role of large triplet repeat length in the development of mental retardation
80. Proximal myotonic myopathy syndrome in the absence of trinucleotide repeat expansions
81. Getting a grip on the myotonic dystrophies
82. Myotonic dystrophy with no trinucleotide repeat expansion
83. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes
84. No evidence that proximal myotonic myopathy (PROMM) is associated with an expanded CTG/CAG repeat
85. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene
86. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: Implications for myotonic dystrophy
87. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion
88. Acetazolamide-responsive myotonia congenita
89. Proximal myotonic dystrophy - A family with autosomal dominant muscular dystrophy, cataracts, hearing loss, and hypogonadism: Heterogeneity of proximal myotonic disorders
90. Cardiac involvement in proximal myotonic myopathy
91. Genetic studies of the myotonic dystrophy CTG repeat
92. A family with PROMM not linked to the recently mapped PROMM locus DM2
93. Is myotonic dystrophy (DM) the result of a contiguous gene defect?
94. Instability of the (CTG)n repeat in congenital myotonic dystrophy
95. Analysis of the CTG repeat in skeletal muscle of young and adult myotonic dystrophy patients: When does the expansion occur?